Should cancer be removed from sPESI score?

M. Bugra Coskuner (Aksaray, Turkey), Y. Bülbül (Trabzon, Turkey), F. Öztuna (Trabzon, Turkey), T. Ozlu (Trabzon, Turkey)

Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Session: Pulmonary embolism in non-COVID-19 and COVID-19 patients
Session type: E-poster
Number: 505

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bugra Coskuner (Aksaray, Turkey), Y. Bülbül (Trabzon, Turkey), F. Öztuna (Trabzon, Turkey), T. Ozlu (Trabzon, Turkey). Should cancer be removed from sPESI score?. 505

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Performance scores in patients with suspected lung cancer: reliability of scoring and impact on treatment
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


The Khorana score as a predictor of mortality in lung  adenocarcinoma
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Fit for surgery? Assessment of marginal lung cancer patients
Source: Breathe 2008; 6: 126-139
Year: 2009

Comorbidity in lung cancer – operated patients. Impact on survival and prognosis
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005

Role of Charlson cormobidity index in the advanced non small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006

Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
Source: Breathe, 16 (4) 394; 10.1183/20734735.0204-2020
Year: 2020



Australia-modified Karnofsky performance scale in patients with COPD and lung cancer patients: A pooled data analysis
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Prognostic value of Nutric score in critically ill patients with lung cancer
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020


Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

Could age-adjusted Charlson comorbidity index predict outcomes in patients submitted to noninvasive ventilation?
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017


Functional independence measure scale in patients with lung cancer after chemotherapy
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008


Is smoking status a prognostic factor in resected lung cancer?
Source: ISSN=ISSN 1810-6838, ISBN=, page=78
Year: 2006

Staging of primary tracheal cancer as stratification of prognosis is it possible?
Source: Annual Congress 2007 - Airway problems: surgical and endoscopic solutions
Year: 2007


6-minute-walk in lung cancer – a new predictor for response and the performance status?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Assessment of the probability of lung cancer diagnosis using authorial predictive scale. Pilot study.
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

Co-morbidity and lung cancer surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 75s
Year: 2005

Mortality predictions of CURB-65, GPS and CALL scores in hospitalized patients with COVID-19
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021


The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Exercise testing to predict lung cancer surgery outcome: which is better - percentage of predicted VO2 or absolute value?
Source: Eur Respir J 2004; 24: Suppl. 48, 672s
Year: 2004

Marginal candidates for lung cancer surgery: is the consensus of real benefit?
Source: Annual Congress 2010 - Selection criteria in lung cancer surgery: what really changed?
Year: 2010